Ontin 5 mg/5 ml (Syrup)
60 ml bottle: ৳ 35.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Cetirizine hydrochloride |
| Company | Eskayef pharmaceuticals ltd |
| Also available as |
Indications
- Relief of symptoms associated with seasonal allergic rhinitis
- Relief of symptoms associated with perennial allergic rhinitis
- Treatment of uncomplicated skin manifestations of chronic idiopathic urticaria
- Treatment of allergen induced asthma
Pharmacology
- Cetirizine Hydrochloride is a potent H1 receptor antagonist
- Does not cause significant anticholinergic effects
- Inhibits histamine-mediated early phase of allergic reaction
- Reduces migration of inflammatory cells
- Reduces release of mediators associated with late phase of allergic reaction
- Plasma half-life of approximately 11 hours
Dosage & Administration
- Recommended daily dosage for adults and children 6 years and older
- Recommended daily dosage for children 2-6 years
- Recommended daily dosage for children 6 months to 2 years
- Injectable dosage form for intravenous administration
- Recommended dosage for adults and adolescents 12 years of age and older for injectable form
- Recommended dosage for children 6 to 11 years of age for injectable form
- Recommended dosage for children 6 months to 5 years of age for injectable form
Interaction
- No clinically significant drug interactions with Theophylline
- No clinically significant drug interactions with Azithromycin
- No clinically significant drug interactions with Pseudoephedrine
- No clinically significant drug interactions with Ketoconazole
- No clinically significant drug interactions with Erythromycin
Contraindications
- Contraindicated in patients with hypersensitivity to Cetirizine
- Contraindicated in patients with hypersensitivity to hydroxyzine
Side Effects
- Most common side effect: somnolence
Pregnancy & Lactation
- US FDA Pregnancy Category: B
- Use during pregnancy only if clearly needed
- Caution when administering to a nursing woman
Precautions & Warnings
- Caution when driving or operating heavy machinery
Use in Special Populations
- Reduced clearance and increased AUC in patients with mild to moderate hepatic and renal impairment
- Safety demonstrated in pediatric patients aged 6 months to 5 years
- Reduced clearance in elderly patients
Therapeutic Class
- Sedating Anti-histamine
Storage Conditions
- Keep in a dry place away from light and heat
- Keep out of the reach of children